Dolutegravir Inhibits Autophagy In Vitro in a Mouse Blood-Brain Barrier Model. [PDF]
Huang C, Qu QR, Bendayan R.
europepmc +1 more source
Impact of antiemetic prophylaxis on reducing trastuzumab deruxtecan dose modifications in HER2+/HER2-low breast cancer. [PDF]
Shin J, Kim JY, Ahn HK, Ahn JS, Park YH.
europepmc +1 more source
Site-Selective Electrochemical Arene C-H Amination. [PDF]
Alvarez EM +5 more
europepmc +1 more source
Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST Study. [PDF]
Loosli T +22 more
europepmc +1 more source
Combined tenofovir, lamivudine, and dolutegravir treatment increases leptin and FABP4 expression in human subcutaneous adipose tissue. [PDF]
Zanardo LW +8 more
europepmc +1 more source
Agent-based simulation of seasonal malaria chemoprevention strategy in Southern Tanzania: comparing dihydroartemisinin-piperaquine with or without primaquine. [PDF]
Mfala CT +4 more
europepmc +1 more source
Novel Piperazine Derivatives of Vindoline as Anticancer Agents. [PDF]
Zsoldos B +9 more
europepmc +1 more source
No evidence of molecular markers of piperaquine resistance in southeastern Nigeria. [PDF]
Ikegbunam M +6 more
europepmc +1 more source
Effectiveness of dolutegravir-based treatment among HIV/AIDS patients in Nkembo Outpatient Treatment Center, Gabon. [PDF]
Mangala C +8 more
europepmc +1 more source
Hepatobiliary Adverse Events Associated With the KRAS p.G12C Inhibitor Sotorasib. [PDF]
Frey C.
europepmc +1 more source

